Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Republic of Korea; Department of Yuhan Biotechnology, School of Health & Wellness Services, Yuhan University, Bucheon 14780, Republic of Korea.
College of Pharmacy, Dongguk University, Goyang 10326, Republic of Korea.
Cell Chem Biol. 2024 Nov 21;31(11):1958-1968.e8. doi: 10.1016/j.chembiol.2024.08.004. Epub 2024 Sep 10.
AIMP2-DX2 (hereafter DX2) is an oncogenic variant of aminoacyl-tRNA synthetase-interacting multifunctional protein 2 (AIMP2) that mediates tumorigenic interactions with various factors involved in cancer. Reducing the levels of DX2 can effectively inhibit tumorigenesis. We previously reported that DX2 can be degraded through Siah1-mediated ubiquitination. In this study, we identified a compound, SDL01, which enhanced the interaction between DX2 and Siah1, thereby facilitating the ubiquitin-dependent degradation of DX2. SDL01 was found to bind to the pocket surrounding the N-terminal flexible region and GST domain of DX2, causing a conformational change that stabilized its interaction with Siah1. Our findings demonstrate that protein-protein interactions (PPIs) can be modulated through chemically induced conformational changes.
AIMP2-DX2(以下简称 DX2)是一种致癌性的氨酰-tRNA 合成酶相互作用多功能蛋白 2(AIMP2)的变体,介导与多种参与癌症的因子发生致癌性相互作用。降低 DX2 的水平可以有效地抑制肿瘤的发生。我们之前的研究报告称,DX2 可以通过 Siah1 介导的泛素化途径进行降解。在本研究中,我们鉴定出一种化合物 SDL01,它可以增强 DX2 与 Siah1 的相互作用,从而促进 DX2 的泛素依赖性降解。SDL01 被发现与 DX2 的 N 端柔性区域和 GST 结构域周围的口袋结合,导致构象发生变化,从而稳定了它与 Siah1 的相互作用。我们的研究结果表明,蛋白质-蛋白质相互作用(PPIs)可以通过化学诱导的构象变化进行调节。